Cormorant Asset Management, LP BBIO Holdings History
Cormorant Asset Management, LP's BridgeBio Pharma Inc Holding Summary
As of 2025-03-31, Cormorant Asset Management, LP held 2.00 Mil shares of BridgeBio Pharma Inc(BBIO), totaling $69.14 Mil. This investment constitutes 5.2% of their stock portfolio, and Cormorant Asset Management, LP now holds 1.05% of the outstanding BridgeBio Pharma Inc(BBIO) stock.
The initial trade took place in 2019Q2. And since then Cormorant Asset Management, LP has made 5 purchases of BBIO, at an average price of $21.11, for a total of 7.30 Mil shares. In addition, there have been 16 sales at an average price of $29.85 for 5.30 Mil shares. Based on historical transaction data and BBIO's current price of $47.23, Cormorant Asset Management, LP's estimated gain on his BBIO holdings is $98.54 Mil, reflecting a 63.94% gain to date.
Cormorant Asset Management, LP BBIO ($47.23) Holding Chart
Cormorant Asset Management, LP BBIO ($47.23) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
